These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6677246)

  • 1. [IgG4 antibody response to phospholipase A in bee keepers].
    Takaishi T; Nakagawa T; Yoshinoya S; Ito K; Miyamoto T; Miyachi S
    Arerugi; 1983 Nov; 32(11):1106-12. PubMed ID: 6677246
    [No Abstract]   [Full Text] [Related]  

  • 2. Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.
    Wetterwald A; Skvaril F; Müller U; Blaser K
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):195-7. PubMed ID: 4008074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of IgG and IgG4 antibodies to bee venom phospholipase A2 by competitive inhibition in ELISA.
    Rieben R; Blaser K
    J Immunol Methods; 1989 Apr; 119(1):1-8. PubMed ID: 2708823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee-venom immunotherapy.
    Devey ME; Lee SR; Richards D; Kemeny DM
    J Allergy Clin Immunol; 1989 Sep; 84(3):326-30. PubMed ID: 2778238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of binding of IgE and IgG antibodies to honeybee venom phospholipase-A.
    Paull BR; Jacob GL; Yunginger JW; Gleich GJ
    J Immunol; 1978 Jun; 120(6):1917-23. PubMed ID: 659884
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy.
    Kemeny DM; McKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH
    Monogr Allergy; 1983; 18():150-2. PubMed ID: 6646134
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological studies on bee-keepers: specific IgG and subclass typing IgG against bee venom and bee venom components.
    Urbanek R; Forster J; Ziupa J; Karitzky D
    Klin Wochenschr; 1980 Nov; 58(22):1257-60. PubMed ID: 7464005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.
    Müller U; Helbling A; Bischof M
    Allergy; 1989 Aug; 44(6):412-8. PubMed ID: 2802114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE antibodies to bee venom, phospholipase A, melittin and wasp venom.
    Jarisch R; Yman L; Boltz A; Sandor I; Janitsch A
    Clin Allergy; 1979 Sep; 9(5):535-41. PubMed ID: 498494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy.
    Kemeny DM; Harries MG; Youlten LJ; Mackenzie-Mills M; Lessof MH
    J Allergy Clin Immunol; 1983 May; 71(5):505-14. PubMed ID: 6601672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bee keepers' IgG and IgE antibody responses to bee venom studied by means of crossed radioimmunoelectrophoresis.
    Nordvall SL; Uhlin T; Einarsson R; Johansson SG; Ohman S
    Clin Allergy; 1984 Jul; 14(4):341-50. PubMed ID: 6205790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response to bee venom. Comparison of the antibody response to phospholipase A2 with the response to inhalant antigens.
    Kemeny DM; Miyachi S; Platts-Mills TA; Wilkins S; Lessof MH
    Int Arch Allergy Appl Immunol; 1982; 68(3):268-74. PubMed ID: 7085123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of IgG4 as blocking antibodies in asthmatics and in bee keepers.
    Nakagawa T; Miyamoto T
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):204-5. PubMed ID: 4008076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to bee venom. II. Quantitation of the absolute amounts of IgE and IgG antibodies by saturation analysis.
    Kemeny DM; Lessof MH
    Int Arch Allergy Appl Immunol; 1987; 83(2):113-20. PubMed ID: 3583409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological studies of beekeepers.
    Light WC; Reisman RE; Wypych JI; Arbesman CE
    Clin Allergy; 1975 Dec; 5(4):389-95. PubMed ID: 1053439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of human antibodies to bee venom phospholipase A2 in vitro.
    Held W; Stucki M; Heusser C; Blaser K
    Scand J Immunol; 1989 Feb; 29(2):203-9. PubMed ID: 2922572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.
    Urbanek R; Kemeny DM; Richards D
    Clin Allergy; 1986 Jul; 16(4):317-22. PubMed ID: 3742787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response gene control of the murine antibody response to the phospholipase A2 of honey bee venom.
    Lucas A; Hamburger RN
    Immunogenetics; 1986; 23(6):417-20. PubMed ID: 3087870
    [No Abstract]   [Full Text] [Related]  

  • 19. [Skin tests, total IgE and venom specific IgE and IgG4 in serum of bee-keepers].
    Nittner-Marszalska M; Małolepszy J; Zak-Nejmark T
    Pneumonol Alergol Pol; 1993; 61(7-8):342-5. PubMed ID: 8401338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of bee venom Api m 1 IgE epitopes and characterization of corresponding mimotopes.
    Zahirović A; Koren A; Kopač P; Štrukelj B; Korošec P; Lunder M
    J Allergy Clin Immunol; 2019 Feb; 143(2):791-794.e5. PubMed ID: 30315830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.